TCL Archive In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved April 4, 1980
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive Cuts From NCI Budget total $38 Million; Prevention Gets $21 Million Increase January 24, 1992